Authors:
CHARLTON PA
FAINT RW
BENT F
BRYANS J
CHICARELLIROBINSON I
MACKIE I
MACHIN S
BEVAN P
Citation: Pa. Charlton et al., EVALUATION OF A LOW-MOLECULAR-WEIGHT MODULATOR OF HUMAN PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY, Thrombosis and haemostasis, 75(5), 1996, pp. 808-815
Authors:
BARNES CS
FAINT RW
DWYER MC
CRITCHLEY DJP
TEMPLETON D
FOLKES AJ
CHARLTON PA
BEVAN P
Citation: Cs. Barnes et al., EFFECTS OF XR5118 ON PAI-1 AND TPA ACTIVITY AND ARTERIAL THROMBUS FORMATION IN THE ANESTHETIZED RAT, British Journal of Pharmacology, 118, 1996, pp. 97-97
Authors:
CHARLTON PA
FAINT RW
BENT F
BRYANS J
MACKIE I
MACHIN S
BEVAN P
Citation: Pa. Charlton et al., A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) INCREASE FIBRINOLYSIS AND PROTECT AGAINST THROMBUSFORMATION IN THE RAT, Thrombosis and haemostasis, 73(6), 1995, pp. 1005-1005
Authors:
FAINT RW
CHARLTON PA
BENT F
BRYANS J
MACKIE I
MACHIN S
BEVAN P
Citation: Rw. Faint et al., THE IN-VITRO EVALUATION OF A SERIES OF LOW-MOLECULAR-WEIGHT INHIBITORS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), Thrombosis and haemostasis, 73(6), 1995, pp. 1007-1007
Authors:
CHARLTON PA
BARNES CS
BENT FM
BRYANS JS
FAINT RW
FOLKES AJ
MACHIN SJ
MACKIE I
BEVAN P
Citation: Pa. Charlton et al., EVALUATION OF A LOW-MOLECULAR-WEIGHT INHIBITOR OF PLASMINOGEN-ACTIVATOR INHIBITOR-1, Circulation, 92(8), 1995, pp. 2320-2320
Authors:
PRICEJONES MJ
CHARLTON PA
BESSANT CM
HARRISON TM
DARKE BM
LEES WE
KAY J
Citation: Mj. Pricejones et al., ANALYSIS OF LATENT FORMS OF RENIN USING ANTIBODIES RAISED AGAINST THEPROPART SEGMENT OF HUMAN PRORENIN - VALIDATION WITH REPRESENTATIVE SAMPLES OF OVARIAN-CYST AND FOLLICULAR FLUIDS, Clinical and experimental hypertension, 15(4), 1993, pp. 619-640